VCEL Q4 2019 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$39M+25.7% YoY

Gross Profit

$29M73.1% margin

Operating Income

$9M23.4% margin

Net Income

$10M24.1% margin

EPS (Diluted)

$0.20

QoQ Revenue Growth

+29.2%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$153M

Total Liabilities

$42M

Stockholders' Equity

$111M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$39M	$31M	+25.7%
Gross Profit	$29M	$23M	+26.9%
Operating Income	$9M	$6M	+53.6%
Net Income	$10M	$5M	+81.2%